Edge For Alpha (@EdgeFromSEC) header
Edge For Alpha (@EdgeFromSEC) profile picture

Tracking insider buying from SEC Form 4 filings. Equal-dollar research portfolio. Early results: +1.68% alpha vs equal-weight S&P (RSP). Data, not advice.

Kokomo, Indiana, USA
Joined June 2025
Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)Photo by Edge For Alpha (@EdgeFromSEC)
I’ve just relaunched EdgeForAlpha. I track real open-market insider buys (SEC Form 4) and compare them to the market. Early research: an equal-dollar insider portfolio shows +1.68% alpha vs the equal-weight S&P 500 (RSP) from Jul–Nov 2025. Data, not advice: edgeforalpha.com
2
753
Open-market buy: $KMI (KINDER MORGAN) — $14,994,200 by Executive Chairman. Not a pre-planned trade. Now holds 246,712,353 shares. Industry: Natural Gas Transmission. Trade date: 2026-11-06.
23
Open-market buy: $MDGL (MADRIGAL PHARMACEUTICALS) — $23,134,106 by Director. Not a pre-planned trade. Now holds 2,024,942 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-11-06.
92
Open-market buy: $KOD (Kodiak Sciences) — $14,965,245 by Director. Not a pre-planned trade. Now holds 20,343,130 shares. Industry: Biological Products, (No Diagnostic Substances). Trade date: 2026-11-04.
34
Open-market buy: $TRAD (APEX Tech Acquisition) — $2,089,710 by CFO. Not a pre-planned trade. Now holds 3,083,971 shares. Industry: Blank Checks. Trade date: 2026-02-27-05:00.
21
Open-market buy: $NONE (Third Point Private Capital Income Fund) — $4,000,000 by 10% Owner. Not a pre-planned trade. Now holds 161,000 shares. Trade date: 2026-11-03.
15
Open-market buy: $NONE (Third Point Private Capital Partners) — $7,691,164 by 10% Owner. Not a pre-planned trade. Now holds 1,933,159 shares. Trade date: 2026-10-01.
24
Open-market buy: $LYEL (Lyell Immunopharma) — $24,999,992 by 10% Owner. Not a pre-planned trade. Now holds 3,747,790 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-11-04.
22
Open-market buy: $PAM (Pampa Energy) — $1,328,432 by President. Not a pre-planned trade. Now holds 710,306 shares. Industry: Electric Services. Trade date: 2026-11-03.
33
Open-market buy: $LBTY (Liberty Global) — $1,995,978 by CTO. Not a pre-planned trade. Now holds 602,378 shares. Industry: Cable & Other Pay Television Services. Trade date: 2026-11-04.
1
44
Open-market buy: $ASPE (Aspen Neuroscience) — $15,000,000 by Director. Not a pre-planned trade. Now holds 3,589,132 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-11-02.
34
Open-market buy: $DOLE (Dole) — $9,832,264 by 10% Owner. Not a pre-planned trade. Now holds 11,266,477 shares. Industry: Agricultural Production-Crops. Trade date: 2026-11-03.
35
Open-market buy: $INTC (INTEL) — $9,709,680 by CEO. Not a pre-planned trade. Now holds 1,464,669 shares. Industry: Semiconductors & Related Devices. Trade date: 2026-11-02.
1
100
Open-market buy: $SIRI (SIRIUS XM HOLDINGS) — $21,494,116 by 10% Owner. Not a pre-planned trade. Now holds 125,551,082 shares. Industry: Radio Broadcasting Stations. Trade date: 2026-10-30.
62
Open-market buy: $LRN (Stride) — $5,775,750 by Director. Not a pre-planned trade. Now holds 2,091,403 shares. Industry: Services-Educational Services. Trade date: 2026-11-02.
46
Open-market buy: $CRBG (Corebridge Financial) — $7,752,318 by 10% Owner. Pre-planned (10b5-1) trade. Now holds 132,340,070 shares. Industry: Life Insurance. Trade date: 2026-10-30.
33
Open-market buy: $N/A (Hamilton Lane Venture Capital & Growth Fund) — $35,000,171 by 10% Owner. Not a pre-planned trade. Now holds 2,396,200 shares. Trade date: 2026-10-29.
20
Open-market buy: $ASPE (Aspen Neuroscience) — $18,000,000 by 10% Owner. Not a pre-planned trade. Now holds 1,200,000 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-11-02.
53
Open-market buy: $ROL (ROLLINS) — $49,956,665 by 10% Owner. Not a pre-planned trade. Now holds 146,728,468 shares. Industry: Services-To Dwellings & Other Buildings. Trade date: 2026-10-29.
30
Open-market buy: $RAPP (Rapport Therapeutics) — $19,999,980 by Director. Not a pre-planned trade. Now holds 2,815,707 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-10-28.
47
Open-market buy: $RAPP (Rapport Therapeutics) — $19,999,980 by Director. Not a pre-planned trade. Now holds 2,815,707 shares. Industry: Pharmaceutical Preparations. Trade date: 2026-10-28.
37